| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.11(B) |
| Last
Volume: |
2,501,317 |
Avg
Vol: |
1,900,163 |
| 52
Week Range: |
$65.11 - $82.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 317 |
| Guru Rank Value : 4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
26,945 |
67,902 |
123,113 |
368,767 |
| Total Sell Value |
$2,043,551 |
$5,004,391 |
$8,902,469 |
$27,563,219 |
| Total People Sold |
3 |
4 |
6 |
10 |
| Total Sell Transactions |
3 |
6 |
8 |
16 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leaming Nancy |
Director |
• • – |
2016-07-11 |
4 |
OE |
$14.50 |
$73,950 |
D/D |
5,100 |
59,032 |
|
- |
|
| Leaming Nancy |
Director |
• • – |
2016-07-08 |
4 |
AS |
$36.00 |
$40,356 |
D/D |
(1,121) |
53,932 |
|
- |
|
| Leaming Nancy |
Director |
• • – |
2016-07-08 |
4 |
OE |
$14.50 |
$16,255 |
D/D |
1,121 |
55,053 |
|
- |
|
| Ullian Elaine |
Director |
• • – |
2016-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
401 |
24,662 |
|
- |
|
| Levy Lawrence M |
Director |
• • – |
2016-06-01 |
4 |
S |
$34.41 |
$612,327 |
D/D |
(17,794) |
21,463 |
|
- |
|
| Levy Lawrence M |
Director |
• • – |
2016-06-01 |
4 |
OE |
$14.50 |
$611,270 |
D/D |
32,071 |
39,257 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2016-05-27 |
4 |
AS |
$33.85 |
$76,366 |
D/D |
(2,256) |
1,257 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP & Chief Acctg Officer |
• • – |
2016-05-26 |
4 |
S |
$33.85 |
$143,130 |
D/D |
(4,228) |
8,847 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP & Chief Acctg Officer |
• • – |
2016-05-26 |
4 |
OE |
$0.00 |
$66,591 |
D/D |
4,753 |
12,881 |
|
- |
|
| Oberton Karleen Marie |
Corp. VP & Chief Acctg Officer |
• • – |
2016-05-26 |
4 |
D |
$33.85 |
$5,619 |
D/D |
(166) |
8,653 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2016-05-26 |
4 |
D |
$33.85 |
$39,097 |
D/D |
(1,155) |
3,513 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2016-05-26 |
4 |
OE |
$0.00 |
$184,986 |
D/D |
11,177 |
4,668 |
|
- |
|
| Valenti Peter J. Iii |
Division Pres., Breast Health |
• • – |
2016-05-26 |
4 |
AS |
$33.83 |
$262,724 |
D/D |
(7,766) |
1,257 |
|
- |
|
| Mcmahon Robert W. |
Chief Financial Officer |
• • – |
2016-05-26 |
4 |
D |
$33.85 |
$80,665 |
D/D |
(2,383) |
12,343 |
|
- |
|
| Mcmahon Robert W. |
Chief Financial Officer |
• • – |
2016-05-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,347 |
14,726 |
|
- |
|
| Ullian Elaine |
Director |
• • – |
2016-05-26 |
4 |
S |
$33.85 |
$233,430 |
D/D |
(6,896) |
24,261 |
|
- |
|
| Ullian Elaine |
Director |
• • – |
2016-05-26 |
4 |
OE |
$14.50 |
$233,030 |
D/D |
16,071 |
31,157 |
|
- |
|
| Compton Eric B. |
COO |
• • – |
2016-04-14 |
4 |
D |
$36.25 |
$48,575 |
D/D |
(1,340) |
8,946 |
|
- |
|
| Compton Eric B. |
COO |
• • – |
2016-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,189 |
10,286 |
|
- |
|
| Coughlin Christopher J |
Director |
– • – |
2016-03-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
| Lavance David R Jr |
Director |
• • – |
2016-02-24 |
4 |
S |
$34.50 |
$400,925 |
D/D |
(11,621) |
9,362 |
|
- |
|
| Lavance David R Jr |
Director |
• • – |
2016-02-24 |
4 |
OE |
$26.74 |
$310,746 |
D/D |
11,621 |
20,983 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2016-02-02 |
4 |
D |
$34.83 |
$31,243 |
D/D |
(897) |
1,478 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2016-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
1,985 |
|
- |
|
| Wilson Wayne |
Director |
• • – |
2016-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,272 |
42,487 |
|
- |
|
824 Records found
|
|
Page 26 of 33 |
|
|
1.20 (1.65%) 
